Interocular conflict from a monocular augmented reality display: Impact of visual characteristics on performance.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 11 04 2021
accepted: 15 08 2021
entrez: 2 9 2021
pubmed: 3 9 2021
medline: 18 11 2021
Statut: epublish

Résumé

In monocular see-through augmented reality systems, each eye is stimulated differently by a monocular image that is superimposed on the binocular background. This can impair binocular fusion, due to interocular conflict. As a function of visual characteristics, the latter can have a greater or lesser impact on user comfort and performance. This study tested several visual characteristics of a binocular background and a monocular element during an exposure that reproduced the interocular conflict induced by a monocular see-through near-eye display. The aim was to identify which factors impact the user's performance. Performance was measured as target tracking and event detection, identification, fixation time, and latency. Our results demonstrate that performance is a function of the binocular background. Furthermore, exogenous attentional stimulation, in the form of a pulse with different levels of contrast applied to the monocular display, appears to preserve performance in most background conditions.

Identifiants

pubmed: 34473744
doi: 10.1371/journal.pone.0256766
pii: PONE-D-21-10305
pmc: PMC8412327
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0256766

Déclaration de conflit d'intérêts

This commercial affiliation does not alter our adherence to Plos One policies on sharing data and materials.

Références

Am J Optom Physiol Opt. 1980 Sep;57(9):640-4
pubmed: 7425087
Vision Res. 1991;31(7-8):1191-203
pubmed: 1891811
Atten Percept Psychophys. 2010 Jul;72(5):1237-43
pubmed: 20601704
Vision Res. 1982;22(7):787-800
pubmed: 7123863
Hum Factors. 2006 Fall;48(3):555-73
pubmed: 17063969
Vision Res. 2001 Jun;41(14):1817-24
pubmed: 11369045
J Vis Exp. 2010 Nov 10;(45):
pubmed: 21113111
Nat Neurosci. 2004 Mar;7(3):308-13
pubmed: 14966522
Vision Res. 2006 May;46(11):1794-803
pubmed: 16368126
Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15508-11
pubmed: 8986842
Vision Res. 2010 Aug 6;50(17):1728-39
pubmed: 20561972
Nat Rev Neurosci. 2002 Jan;3(1):13-21
pubmed: 11823801
Vision Res. 1992 Aug;32(8):1471-9
pubmed: 1455720
Perception. 1999;28(5):551-74
pubmed: 10664754
Perception. 1983;12(4):447-56
pubmed: 6672740
Sci Rep. 2020 May 26;10(1):8673
pubmed: 32457469
Vision Res. 1999 Oct;39(26):4341-53
pubmed: 10789428
Percept Psychophys. 1980 Jun;27(6):550-6
pubmed: 7393703
Invest Ophthalmol Vis Sci. 1986 Apr;27(4):558-64
pubmed: 3957575
Vision Res. 1997 Jan;37(2):175-83
pubmed: 9068818
Science. 1978 Jun 30;200(4349):1497-9
pubmed: 663633
Percept Psychophys. 1985 Feb;37(2):114-24
pubmed: 4011364
Vis Neurosci. 1992 May;8(5):469-78
pubmed: 1586647

Auteurs

Elodie Bayle (E)

Thales AVS, France SAS, Mérignac, France.
French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France.
IBISC, Evry University, Paris Saclay University, Evry, France.

Sylvain Hourlier (S)

Thales AVS, France SAS, Mérignac, France.

Sylvie Lelandais (S)

IBISC, Evry University, Paris Saclay University, Evry, France.

Charles-Antoine Salasc (CA)

French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France.

Laure Leroy (L)

French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France.
Paris 8 University, Saint-Denis, France.

Justin Plantier (J)

French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France.
IBISC, Evry University, Paris Saclay University, Evry, France.

Pascaline Neveu (P)

French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH